Media hub
-
New drug target identified for inflammatory lung disease
Researchers at the Centenary Institute and the University of Technology Sydney have identified a new drug target for the treatment and prevention of chronic obstructive pulmonary disease (COPD), an inflammatory lung disease that causes airway blockage and that makes it difficult to breathe.News Type: Media releaseDate -
The Centenary Institute is excited to join the Sydney Biomedical Accelerator (SBA) as primary medical research partner
The Centenary Institute welcomes the NSW Government’s commitment to fund a new biomedical complex in Camperdown. The Chair of the Centenary Institute Board, Joseph Carrozzi AM, and its Executive Director, Professor Mathew Vadas AO, are thrilled that a biomedical complex, the Sydney Biomedical Accelerator (SBA), will now be a reality.News Type: Media releaseDate -
World-first study reveals why people with COPD are more susceptible to COVID-19
Researchers from the Centenary Institute and the University of Technology Sydney have published the first study showing why people with chronic obstructive pulmonary disease (COPD) are at higher risk of developing severe COVID-19.News Type: Media releaseDate -
New discovery may hold key to fighting deadly infections
Centenary Institute research has revealed new insight into tackling mycobacterial infections which are responsible for chronic diseases that include tuberculosis (TB), leprosy and serious skin ulcerations.News Type: Media releaseDate -
Early detection of lung cancer to be investigated
Dr Annalicia Vaughan from the Centenary UTS Centre for Inflammation is the successful recipient of the Kenyon Foundation Inflammation Award for 2022. The Award, valued at $20,000, will support Dr Vaughan’s study into identifying new microbial-derived biomarkers for the early diagnosis and treatment of lung cancer. The leading cause of cancer death, lung cancer is ...News Type: Media releaseDate -
Researchers shed new light on devastating drug-resistant bacteria
Centenary Institute researchers have uncovered new insight into Mycobacterium abscessus, a highly drug-resistant bacteria that can cause serious infection and lung damage in vulnerable people. The bacteria is considered an emerging health threat with infection numbers on the rise globally. Commonly found in soil, dust and water, Mycobacterium abscessus is closely related to the bacteria ...News Type: Media releaseDate -
New discovery to aid treatment of problem infant hemangiomas
Research led by the Centenary Institute and the Harvard Medical School, Boston, shows that a compound present in current beta blocker treatments could be repurposed to increase efficiency and safety of infantile hemangioma therapies.News Type: Media releaseDate -
Over $4 million in grants to boost cancer research at the Centenary Institute
Two Centenary Institute scientists have been awarded grants totalling $4.3 million from the Cancer Institute NSW to undertake critical cancer related medical research.News Type: Media releaseDate -
New precision medicine laboratory to help fight cancer
The Centenary Institute has announced it will establish a new precision medicine laboratory, enabling world-leading research into the use of theranostics to treat cancer, thanks to a grant from the Australian Cancer Research Foundation (ACRF).News Type: Media releaseDate -
Researchers find new target to combat lung disease
Research led by the Centenary Institute and University of Technology Sydney has identified a small RNA molecule called microRNA-21 as a therapeutic target and its inhibition as a potential treatment for chronic obstructive pulmonary disease (COPD).News Type: Media releaseDate -
Centenary Institute receives $1.8m in funding for cardiovascular research
World-leading research into cardiovascular disease has been boosted with three researchers from the Centenary Institute securing Cardiovascular Research Capacity Program grants from the NSW Government.News Type: Media releaseDate -
Aspirin could make urinary tract infections worse
New research by the Centenary Institute suggests that commonly prescribed anticoagulants – medicines, such as aspirin, that help prevent blood clots – may make urinary tract infections (UTIs) more severe.News Type: Media releaseDate